InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Branning Todd P., 首席财务官. Director active across 1 company, notably NeuBase Therapeutics, Inc.. In total, 3 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €31k. History available since 16 March 2022. The latest transaction was filed on 16 March 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Todd P. Branning is the Chief Financial Officer of NeuBase Therapeutics, Inc. He is responsible for the company's financial management, including financial planning, risk management, and investment strategy. His role is essential in ensuring the financial health and growth of NeuBase.